Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2022)
Alnylam Pharmaceuticals' (ALNY) quarterly Debt Ratio came in at 0.2 in Q2 2022, up 64.87% YoY from 0.12 in Q2 2021, and up 3.25% on a QoQ basis from 0.2 in Q1 2022.
Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2022) Analysis & Trends
Alnylam Pharmaceuticals (ALNY) has 7 years of Debt Ratio data on file, last reported at 0.2 in Q2 2022.
- Quarterly Debt Ratio rose 64.87% year-over-year to 0.2 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was 0.2 (up 64.87% YoY) and the FY2021 annual result came in at 0.19, up 230.35% from the prior year.
- Debt Ratio improved to 0.2 in Q2 2022, from 0.2 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.2 in Q2 2022 to a low of 0.01 in Q2 2019.
- A 5-year average of 0.08 and a median of 0.06 in 2020 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2018 — Debt Ratio tumbled 88.21% — and 2022, when it surged 234.87%.
- Tracing ALNY's Debt Ratio over 5 years: stood at 0.02 in 2018, then plunged by 42.03% to 0.01 in 2019, then jumped by 408.35% to 0.06 in 2020, then jumped by 230.35% to 0.19 in 2021, then increased by 9.72% to 0.2 in 2022.
- The last three Debt Ratio figures came in at 0.2 (Q2 2022), 0.2 (Q1 2022), and 0.19 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 0.20 |
| Mar 31, 2022 | 0.20 |
| Dec 31, 2021 | 0.19 |
| Sep 30, 2021 | 0.12 |
| Jun 30, 2021 | 0.12 |
| Mar 31, 2021 | 0.06 |
| Dec 31, 2020 | 0.06 |
| Jun 30, 2019 | 0.01 |
| Mar 31, 2019 | 0.01 |
| Dec 31, 2018 | 0.02 |
| Sep 30, 2018 | 0.02 |
| Jun 30, 2018 | 0.02 |
| Mar 31, 2018 | 0.02 |
| Dec 31, 2017 | 0.02 |
| Sep 30, 2017 | 0.11 |
| Jun 30, 2017 | 0.10 |
| Mar 31, 2017 | 0.13 |
| Dec 31, 2016 | 0.12 |
| Sep 30, 2016 | 0.11 |
| Jun 30, 2016 | 0.11 |